180 related articles for article (PubMed ID: 2449025)
21. Whither interferon for myeloma and other hematologic malignancies?
Alexanian R; Weber D
Ann Intern Med; 1996 Jan; 124(2):264-5. PubMed ID: 8534004
[No Abstract] [Full Text] [Related]
22. Progress toward therapeutic application of interferons, 1979-1983.
Borden EC
Cancer; 1984 Dec; 54(11 Suppl):2770-6. PubMed ID: 6208992
[TBL] [Abstract][Full Text] [Related]
23. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
24. Drug therapy for neoplastic disease in adults.
Votaw ML; Bull FE
Med Clin North Am; 1969 Nov; 53(6):1265-78. PubMed ID: 4900716
[No Abstract] [Full Text] [Related]
25. New agents for the treatment of multiple myeloma and non-Hodgkin lymphoma.
Oken MM
Cancer; 1992 Aug; 70(4 Suppl):946-8. PubMed ID: 1638466
[TBL] [Abstract][Full Text] [Related]
26. The clinical utility of lenalidomide in multiple myeloma and myelodysplastic syndromes.
Bonkowski J; Vermeulen LC; Kolesar JM
J Oncol Pharm Pract; 2010 Dec; 16(4):223-32. PubMed ID: 19910392
[TBL] [Abstract][Full Text] [Related]
27. [Bortezomib].
Simons S; Scheulen ME; Jaehde U
Dtsch Med Wochenschr; 2006 Feb; 131(5):214-8. PubMed ID: 16440269
[No Abstract] [Full Text] [Related]
28. [Role of interferon for the treatment of myeloma].
Tomita S; Okamoto S
Nihon Rinsho; 2007 Dec; 65(12):2285-90. PubMed ID: 18069274
[TBL] [Abstract][Full Text] [Related]
29. 5'-Azacitidine for therapy-related myelodysplastic syndromes after non-Hodgkin lymphoma treatment.
Breccia M; Salaroli A; Loglisci G; Martelli M; D'Elia GM; Nanni M; Mauro FR; Alimena G
Leuk Res; 2011 Oct; 35(10):1409-11. PubMed ID: 21680017
[TBL] [Abstract][Full Text] [Related]
30. [Programs for continuing medical education: B session 7. Progress in treatment for hematologic diseases].
Higashihara M
Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):717-23. PubMed ID: 24796142
[No Abstract] [Full Text] [Related]
31. Interferons in oncology.
Woll PJ; Pettengell R
Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
[TBL] [Abstract][Full Text] [Related]
32. [Clinical effects of stearyl-ara-CMP (YNK-01) on chronic hematologic malignancies].
Im T; Ota K; Ohira H; Yasui Y; Nakao Y; Furukawa Y; Inoue K; Yamane T; Hiyoshi M; Kishida T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):139-42. PubMed ID: 1987896
[No Abstract] [Full Text] [Related]
33. Why do so many cancer patients fail to respond to interferon therapy?
Einhorn S; Grander D
J Interferon Cytokine Res; 1996 Apr; 16(4):275-81. PubMed ID: 9162520
[TBL] [Abstract][Full Text] [Related]
34. [Thymostimulin as an adjuvant to antineoplastic chemotherapy. Experience with patients with myeloma and lymphoma].
Cánovas Fernández A; González de Zárate P; Alonso Alonso J; Aguirre Errasti C
Rev Clin Esp; 1988 Nov; 183(7):340-3. PubMed ID: 3212263
[No Abstract] [Full Text] [Related]
35. [Biological activity of human alpha-interferons studied using specific antisera].
Korsun NS; Nosik DN; Novokhatskiĭ AS; Trushinskaia GN
Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
[TBL] [Abstract][Full Text] [Related]
36. [Topotecan: a new field of use].
Ferrari S; Danova M
Tumori; 1999; 85(6 Suppl 1):S23-8. PubMed ID: 10786197
[TBL] [Abstract][Full Text] [Related]
37. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
Wagstaff J; Scarffe JH; Crowther D
Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
[No Abstract] [Full Text] [Related]
38. [Antitumor effects of interferon (author's transl)].
Nagata I
Tanpakushitsu Kakusan Koso; 1976 Apr; 21(4):271-7. PubMed ID: 796877
[No Abstract] [Full Text] [Related]
39. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
Lee SH; Kelley S; Chiu H; Stebbing N
Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
[TBL] [Abstract][Full Text] [Related]
40. Interferons in the treatment of multiple myeloma.
Ohno R
Int J Cancer Suppl; 1987; 1():14-20. PubMed ID: 2442112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
